The effect of tryptophan depletion on the action of haloperidol in MK-801-treated rats

European Journal of Pharmacology

Volumn 502, Issue 1-2, 2004, Pages 109-116

  Bubeníková, Věra ^a   Horáček, Jiří ^a,b   Kožený, Jiří ^a,b   Platilová, Veronika ^a   Závěšická, Lucie ^a   Páleníček, Tomáš ^a,b   Höschl, Cyril ^a,b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

(Rat); Haloperidol; MK 801; Schizophrenia; Serotonin; Tryptophan depletion

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; DIZOCILPINE; HALOPERIDOL; NEUROLEPTIC AGENT; SEROTONIN; TRYPTOPHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; EXPERIMENTAL MODEL; FRONTAL CORTEX; MALE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

ANIMALS; CEREBRAL CORTEX; DIZOCILPINE MALEATE; HALOPERIDOL; MALE; MOTOR ACTIVITY; RATS; RATS, WISTAR; SEROTONIN; TRYPTOPHAN;

EID: 4744361663     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.08.034     Document Type: Article

References (40)

1. P. Andine, N. Widermark, R. Axelsson, G. Nyberg, U. Olofsson, E. Martensson, and M. Sandberg Characterisation of MK-801-induced behaviour as a putative rat model of psychosis J. Pharmacol. Exp. Ther. 290 1999 1393 1408
2. N.A. Anis, S.C. Berry, N.R. Burton, and D. Lodge The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurons by N-methyl-aspartate Br. J. Pharmacol. 79 1983 565 575
3. N. Bel, and F. Artigas Reduction of serotonergic function in rat brain by tryptophan depletion: effects in control and fluvoxamine-treated rats J. Neurochem. 67 1996 669 676
4. C. Bell, J. Abrams, and D. Nutt Tryptophan depletion and its implications for psychiatry Br. J. Psychiatry 178 2001 399 405
5. F. Benedetti, and E.A. Moja Failure of a tryptophan-free amino acid mixture to modify sexual behavior in the female rats Physiol. Behav. 54 1993 1235 1237
6. C.M. Brown, P.J. Fletcher, and D.V. Coscina Acute amino acid loads that deplete brain serotonin fail to alter behaviour Pharmacol. Biochem. Behav. 59 1998 115 121
7. V. Bubeńková, J. Horáĉek, V. Platilová, R. Bahbouh, and F. Ŝt'astný The effect of tryptophan depletion in animal model of schizophrenia Psychiatrie 6 Suppl. 1 2002 12
8. P.F. Buckley Aripiprazole: Efficacy and tolerability profile of a novel-acting atypical antipsychotic Drugs Today (Barc) 39 2003 145 151
9. R.R. Conley, and D.L. Kelly Current status of antipsychotic treatment Curr. Drug Targets. CNS Neurol. Disord. 1 2002 123 128
10. F. Fadda Tryptophan-free diets: a tool to study brain serotonin function News Physiol. Sci. 15 2000 260 264
11. F. Fadda, S. Cocco, and R. Stancampiano A physiological method to selectively decrease brain serotonin release Brain Res. Brain Res. Protoc. 5 2000 219 222
12. G.L. Gessa, G. Biggio, F. Fadda, G.U. Corsini, and A. Tagliamonte Tryptophan-free diet: a new means for rapidly decreasing brain tryptophan content and serotonin synthesis Acta Vitaminol. Enzymol. 29 1975 72 78
13. M.J. Ginski, and J.M. Witkin Sensitive and rapid behavioural differentiation of N-methyl-d-aspartate receptor antagonists Psychopharmacology 114 1994 573 582
14. K.L. Golightly, J.A. Lloyd, J.E. Hobson, P. Gallagher, G. Mercer, and A.H. Young Acute tryptophan depletion in schizophrenia Psychol. Med. 31 2001 75 84
15. U. Heresco-Levy Glutamatergic neurotransmission modulation and the mechanism of antipsychotic atypicality Prog. Neuro-psychopharmacol. Biol. Psychiatry 27 2003 1113 1123
16. J. Horáĉek Novel antipsychotics and extrapyramidal side effects. Theory and Reality Pharmacopsychiatry 33 2000 34 42
17. M.M. Iravani, R. Muscat, and Z.L. Kruk MK-801 interaction with the 5-HT transporter: a real-time study in brain slices using fast cyclic voltammetry Synapse 32 1999 212 224
18. S. Kapur, and P. Seeman Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics? A new hypothesis Am. J. Psychiatry 158 2001 360 369
19. S. Kapur, M.L. Wadenberg, and G. Remington Are animal studies of antipsychotics appropriately dosed? Lessons from the bedside to the bench Can. J. Psychiatry 45 2000 241 246
20. T. Klaassen, W.J. Riedel, N.E. Deutz, and H.M. VanPraag Mood congruent memory bias induced by tryptophan depletion Psychol. Med. 32 2002 167 172
21. K. Krebs-Thomson, V. Lehmann-Masten, S. Naiem, M.P. Paulus, and M.A. Geyer Modulation of phencyclidine-induced changes in locomotor activity and patterns in rats by serotonin Eur. J. Pharmacol. 343 1998 135 143
22. P. Martin, N. Waters, S. Waters, A. Carlsson, and M.L. Carlsson MK-801-induced hyperlocomotion: Differential effects of M100907, SDZ PSD 958 and raclopride Eur. J. Pharmacol. 335 1997 107 116
23. R. Meddis Statistics Using Ranks: A Unified Approach 1984 Basil Blackwell Pub. New York
24. H.Y. Meltzer, and G.A. Gudelsky Dopaminergic and serotonergic effects of clozapine. Implications for a unique clinical profile Arzneim.-Forsch. 42 1992 268 272
25. H.Y. Meltzer, Z. Li, Y. Kaneda, and J. Ichikawa Serotonin receptors: their key role in drugs to treat schizophrenia Prog. Neuro-psychopharmacol. Biol. Psychiatry 27 2003 1159 1172
26. L.P. Miller, W.M. Pardridge, L.D. Braun, and W.H. Oldendorf Kinetic constants for blood-brain barrier amino acid transport in conscious rats J. Neurochem. 45 1985 1427 1432
27. E.A. Moja, P. Cipolla, D. Castoldi, and O. Tofanetti Dose-response decrease in plasma tryptophan and in brain tryptophan and serotonin after tryptophan-free amino acid mixtures in rats Life Sci. 44 1989 971 976
28. I. Ninan, and S.K. Kulkarni 5-HT2A receptor antagonists block MK-801-induced stereotypy and hyperlocomotion Eur. J. Pharmacol. 358 1998 111 116
29. M. Patthy, and R. Gyenge Perfluorinated acids as ion-pairing agents in the determination of monoamine transmitters and some prominent metabolites in rat brains by high-performance liquid chromatography with amperometric detection J. Chromatogr. 419 1988 191 205
30. A. Plałaźnik, M. Jessa, and M. Nazar The behavioural effects of NMDA antagonist in serotonin depleted rats Pharmacol. Biochem. Behav. 58 1997 159 166
31. G. Remington Understanding antipsychotic a typicality: a clinical and pharmacological moving target Psychiatry Neurosci. 28 2003 275 284
32. E. Richelson Receptor pharmacology of neuroleptics: relation to clinical effects J. Clin. Psychiatry 101 1999 5 14
33. R.B. Rosse, J.P. Collins, M. Fay-McCarthy, T.N. Alim, R.J. Wyatt, and S.I. Deutsch Phenomenologic comparison of the idiopathic psychosis of schizophrenia and drug-induced cocaine and phencyclidine psychoses: a retrospective study Clin. Neuropharmacol. 17 1994 359 369
34. B.L. Roth, D. Sheffler, and S.G. Potkin A typical antipsychotic drug actions: unitary or multiple mechanisms for "atypicality"? Clin. Neurosci. Res. 3 2003 108 117
35. A.W. Schmidt, L.A. Lebel, H.R. Howard, and S.H. Zorn Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile Eur. J. Pharmacol. 425 2001 197 201
36. J.A. Schmitt, B.L. Jorissen, S. Sobczak, M.P. van Boxtel, E. Hogervorst, N.E. Deutz, and W.J. Riedel Tryptophan depletion impairs memory consolidation but improves focussed attention in healthy young volunteers J. Psychopharmacol. 14 2000 21 29
37. F.M. Shansis, J.V. Busnello, J. Quevedo, L. Forster, S. Young, I. Izquierdo, and F. Kapczinski Behavioural effects of acute tryptophan depletion in healthy male volunteers J. Psychopharmacol. 14 2000 157 163
38. R.P. Sharma, L.E. Shapiro, S.K. Kamath, E.A. Soll, M.D. Watanabe, and J.M. Davis Acute dietary tryptophan depletion: effects on schizophrenic positive and negative symptoms Neuropsychobiology 35 1997 5 10
39. S.H. Snyder Phencyclidine Nature 285 1980 355 356
40. 1A serotonin receptors in the rat brain Brain Res. 756 1997 84 91